BMY· Biotech / HealthcareGrade B

Bristol-Myers Squibb Company

Composite 0.6252w position 44.6%PER 15.9ROE 38.7%

Quant Factor Breakdown

Quality0.67
Value0.51
Momentum0.60
Growth0.77

Six-factor quant model · scaled 0–1 · Higher is stronger relative to peer universe.

Fundamentals

P/E Ratio15.94
P/B Ratio5.79
ROE38.7%
Operating Margin33.0%
Revenue Growth2.6%
EPS3.57
Dividend Yield4.53%
Debt Ratio231.0%
Free Cash Flow$9.85B
Market Cap$116.19B

Source: Yahoo Finance · Synced daily · Dividend yield expressed as decimal percent.

Trend Signals

RSI (14)40
Momentum Factor0.60

Sector Position

neutral
Biotech / HealthcareScore 584 stocks in universe

Peers in sector

INCYIncyte Corporation
PER 14.5ROE 30.8%
CIThe Cigna Group
PER 2.6ROE 16.3%
069620.KSDaewoong Pharmaceutical Co., Ltd
PER 6.5ROE 19.1%
AMGNAmgen Inc.
PER 24.3ROE 101.3%
EXELExelixis, Inc.
PER 17.5ROE 41.0%

AI Insight

Marcus AI flagged Bristol-Myers Squibb Company (BMY) at composite score 0.62 (Grade B). Quant signals show quality 67, value 51, momentum 60.